Abstract
We present a clinical decision support (CDS) framework to promote goal-concordant care for cancer patients nearing end of life, enabled by a 90-day mortality prediction model. Design, workflow, and deployment for four model driven CDS tools are described alongside utilization patterns and detailed performance analysis of the first of such tools integrated into clinical practice: an alert promoting advance directive completion. The alert achieved a precision of 44.1% (95% CI: 39.6 - 48.8%) and a recall of 34% (95% CI: 30.3 - 37.4%) with 9.8% 90-day mortality prevalence over a period of 8 months. Our analysis shows that both precision and recall of the alert were significantly impacted by the underlying clinical workflows. Based on feedback, clinicians have accepted model-driven CDS as a legitimate means to prioritize patients for advance care planning interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
City of Hope Institutional Review Board gave approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
* Presented at the 2022 AMIA AI Evaluation Showcase, Stage II, Clinical Informatics Conference, Houston, May 2022.
Data Availability
The data associated with the current study is not publicly available as the data are not legally certified as being deidentified. Summary data may be available by contacting the corresponding author.
